{"gene":"TCF7","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":1991,"finding":"TCF-1 was identified and cloned as a T lymphocyte-specific transcription factor containing a single sequence-specific HMG box that binds a heptamer motif in the CD3-epsilon enhancer; upon cotransfection into non-T cells, TCF-1 transactivated through its cognate motif, establishing it as a T cell-specific transcriptional activator.","method":"Protein purification, gel retardation assay, cotransfection/reporter assay, cDNA cloning","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — original cloning paper with in vitro binding assay, functional transactivation assay, and replicated across multiple subsequent studies","pmids":["1989880"],"is_preprint":false},{"year":1991,"finding":"Murine TCF-1 recognizes the same sequence motif in the CD3-epsilon enhancer as human TCF-1, and the HMG box region alone is sufficient for sequence-specific DNA binding; TCF-1 also binds specifically to a functional element in the TCR-alpha enhancer.","method":"Gel retardation assay, methylation interference, deletion analysis, Northern blot, in situ hybridization","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal in vitro assays with deletion mapping; replicated in independent lab","pmids":["1827138"],"is_preprint":false},{"year":1991,"finding":"TCF-1 binds specifically to the T beta 5 element of the TCR-beta enhancer and the T delta 7 element of the TCR-delta enhancer, defining a consensus motif A/T A/T CAAA/GAG recognized by TCF-1 across multiple T cell-specific gene enhancers.","method":"Gel retardation analysis","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro binding assay, single lab, single method","pmids":["1836958"],"is_preprint":false},{"year":1992,"finding":"The HMG boxes of TCF-1 and SRY recognize the heptamer motif predominantly through contacts in the minor groove of DNA, not the major groove, as demonstrated by methylation interference and DEPC carbethoxylation interference footprinting, and by T-to-C and A-to-inosine substitutions that change major groove but not minor groove surfaces.","method":"Methylation interference footprinting, DEPC interference footprinting, base substitution analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods establishing mechanism of DNA recognition in a single rigorous study","pmids":["1639073"],"is_preprint":false},{"year":1993,"finding":"TCF-1/hLEF contains a context-dependent transcriptional activation domain (approximately amino acids 80–256) that is separate from the HMG box and is preferentially active in T cells; this activation domain requires TCF-2 binding at flanking sites within the TCR-alpha enhancer for full activity, demonstrating cooperative enhancer function.","method":"GAL4 fusion transactivation assay, deletion mutagenesis, clustered amino acid substitution, cotransfection/reporter assay in T cell lines","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution with GAL4 fusions plus multiple deletion/substitution mutants in a single rigorous study","pmids":["8253387"],"is_preprint":false},{"year":1995,"finding":"Human TCF-1 protein is expressed exclusively in the nucleus of T lineage cells in normal tissues, produces multiple isoforms (25–55 kDa) by alternative splicing, and is detectable in all stages of T cell malignancy tested, consistent with a T cell-specific nuclear transcription factor function.","method":"Monoclonal antibody generation, Western blot, immunohistochemistry, immunocytochemistry","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct protein localization by antibody-based methods, multiple tissues, single lab","pmids":["7579399"],"is_preprint":false},{"year":1996,"finding":"TCF-1 is encoded by an extensively alternatively spliced gene with a dual-promoter architecture; an alternative upstream promoter adds 116 amino acids to the N-terminus, producing isoforms resembling LEF-1 that can transactivate through the TCR-alpha enhancer, while shorter isoforms lack this capacity, establishing functional differences between TCF-1 isoforms.","method":"Western blot, cDNA cloning, 5' RACE, PCR, cotransfection/reporter assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal methods (cloning, RACE, functional reporter assay) establishing isoform-specific functional differences","pmids":["8622675"],"is_preprint":false},{"year":1998,"finding":"TCF-1 deficiency causes progressive failure of thymocyte expansion at two DN stages (CD44+CD25+ and CD44-CD25-) normally characterized by extensive proliferation; this defect is cell-intrinsic as Tcf-1-/- progenitors fail to expand in normal thymic environments, implicating TCF-1 (as a Wnt/beta-catenin effector) in driving DN thymocyte proliferation.","method":"Tcf-1 knockout mouse analysis, fetal thymic organ culture, intrathymic injection of knockout progenitors, flow cytometry","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean loss-of-function in vivo plus cell-intrinsic rescue experiments with defined cellular phenotype","pmids":["9780167"],"is_preprint":false},{"year":1999,"finding":"TCF-1 binds to two sites in the Ly49A promoter and regulates its transcriptional activity; TCF-1 determines the size of the Ly49A NK cell subset in vivo in a dosage-dependent manner, establishing TCF-1 as a trans-acting factor for clonal NK cell receptor acquisition.","method":"Gel shift/promoter binding assay, Tcf-1 knockout and heterozygous mouse analysis, flow cytometry","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct promoter binding demonstrated plus in vivo dosage-dependent phenotype","pmids":["10549625"],"is_preprint":false},{"year":1999,"finding":"In T cells, TCF-1 becomes transcriptionally active through interaction with beta-catenin, indicating the Wnt signal transduction pathway is operational in T lymphocytes; however, unlike fibroblasts, GSK-3beta inhibition alone (by lithium or dominant-negative GSK-3beta) is insufficient to activate TCF-dependent transcription in T cells, revealing a cell-type-specific difference in Wnt pathway regulation.","method":"TCF reporter assay in T cells vs. fibroblasts, dominant-negative GSK-3beta expression, lithium treatment, cotransfection","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assays in two cell types with multiple perturbations, single lab","pmids":["10221643"],"is_preprint":false},{"year":2001,"finding":"The beta-catenin-binding domain of TCF-1 is required for survival of immature CD4+CD8+ double-positive thymocytes; loss of TCF-1 leads to Bcl-xL downregulation and accelerated apoptosis, which is rescued by a Bcl-2 transgene, placing TCF-1/beta-catenin upstream of anti-apoptotic gene expression in thymocyte survival.","method":"TCF-1 knockout mouse analysis with catenin-binding domain mutant knock-in, Bcl-2 transgene rescue, flow cytometry, Western blot","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic rescue experiment with domain-specific mutant and transgenic rescue, epistasis established","pmids":["11477404"],"is_preprint":false},{"year":2001,"finding":"Wnt1 and Wnt4 signals activate TCF-dependent transcriptional activity in thymocytes (demonstrated using TCF-LacZ reporter mice); the interaction of beta-catenin with TCF-1 is required for full thymocyte development, and retroviral expression of soluble Wnt receptor mutants blocking Wnt signaling inhibits thymocyte development in vitro.","method":"TCF-LacZ reporter mice, retroviral expression of dominant-negative Wnt receptor, in vitro thymocyte culture, flow cytometry","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo reporter assay plus functional blockade experiment placing TCF-1 as downstream effector of Wnt in thymus","pmids":["11265645"],"is_preprint":false},{"year":2005,"finding":"TCF-1 ensures survival of pre-TCR+ thymocytes via its N-terminal catenin-binding domain; pre-TCR signaling significantly induces TCF-1 expression and activates a Wnt/catenin/TCF reporter transgene in vivo, while Wnt signals provide beta-catenin as coactivator, demonstrating cooperation between pre-TCR and Wnt/TCF-1 pathways for thymocyte survival.","method":"TCF-1 catenin-binding domain mutant mice, TCF reporter transgene in vivo, gamma-catenin knockout analysis, flow cytometry","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — domain-specific genetic dissection plus in vivo pathway reporter, single lab, multiple orthogonal approaches","pmids":["15890681"],"is_preprint":false},{"year":2010,"finding":"TCF-1 programs CD8 memory T cell fate; Tcf-1-deficient CD8 T cells lack memory precursor cells (detectable at peak of primary response) and fail to expand upon secondary challenge; this function requires the catenin-binding domain in TCF-1 and depends on beta-catenin and gamma-catenin as coactivators, establishing the Wnt/TCF-1 pathway as essential for CD8 central memory differentiation.","method":"Tcf-1 knockout mouse, LCMV infection model, adoptive transfer, catenin-binding domain mutant analysis, flow cytometry","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined phenotype, domain-specific requirement established, mechanistic pathway placement","pmids":["20457902"],"is_preprint":false},{"year":2011,"finding":"TCF-1 represses IL-17 gene expression via epigenetic modifications during T cell development; TCF-1 deficiency leads to hyperacetylation and H3K4 trimethylation (active marks) at the IL-17 locus in thymocytes, and this epigenetic state is maintained in peripheral T cells, demonstrating TCF-1 maintains chromatin in a repressive state at the IL-17 locus.","method":"Tcf-1 knockout mouse, chromatin immunoprecipitation (ChIP) for histone marks, Rag1-/- reconstitution, flow cytometry, EAE model","journal":"PLoS ONE","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating epigenetic mechanism plus in vivo reconstitution with defined phenotypic readout","pmids":["21935461"],"is_preprint":false},{"year":2011,"finding":"TCF-1 is a critical regulator of T-lineage specification; forced expression of TCF-1 in bone marrow progenitors drives T-lineage development even in the absence of T-inductive Notch1 signals, and TCF-1 upregulates T-cell essential genes including Gata3, Bcl11b, and TCR components, placing TCF-1 downstream of Notch in a T cell specification cascade.","method":"Conditional TCF-1 overexpression in bone marrow progenitors, Notch1-deficient background, flow cytometry, gene expression analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function epistasis experiment in defined genetic background with multiple downstream target validation","pmids":["21814277"],"is_preprint":false},{"year":2012,"finding":"TCF-1 directly represses LEF-1 expression in early thymocytes; Tcf7-/- mice develop T cell malignancy resembling T-ALL in which LEF-1 is aberrantly upregulated, and conditional inactivation of Lef1 greatly delayed or prevented malignancy in Tcf7-/- mice, establishing TCF-1 as a direct transcriptional repressor of LEF-1 and a tumor suppressor in T cell development.","method":"Tcf7 knockout mouse, conditional Lef1 knockout rescue, ChIP (direct repression), flow cytometry, histopathology","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding/repression by ChIP plus genetic epistasis rescue experiment, two orthogonal approaches","pmids":["23103132"],"is_preprint":false},{"year":2014,"finding":"TCF-1 and LEF-1 promote CD4+ T cell fate by directly and positively regulating the transcription factor Th-POK; additionally, TCF-1 physically interacts with Runx3 to cooperatively silence Cd4 in CD8-lineage T cells, demonstrating TCF-1 operates through distinct molecular interactions (Th-POK activation; Runx3 cooperation) to specify helper vs. cytotoxic T cell identity.","method":"Conditional knockout in DP thymocytes, Co-immunoprecipitation (TCF-1/Runx3 interaction), ChIP, flow cytometry","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with defined lineage phenotype, direct protein interaction by Co-IP, ChIP for target regulation, multiple orthogonal methods","pmids":["24836425"],"is_preprint":false},{"year":2015,"finding":"TCF-1 initiates TFH differentiation by directly binding the Bcl6 promoter to promote Bcl-6 expression and the Prdm1 5' regulatory regions to repress Blimp1 expression, placing TCF-1 as a transcriptional hub upstream of the Bcl-6/Blimp1 axis for TFH cell commitment.","method":"ChIP (direct promoter binding), Tcf7 conditional knockout, viral infection model, flow cytometry","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct promoter occupancy by ChIP, loss-of-function phenotype, dual target validation in one study","pmids":["26214740"],"is_preprint":false},{"year":2015,"finding":"LEF-1 and TCF-1 cooperatively regulate TFH differentiation by establishing responsiveness of naive CD4+ T cells to TFH signals and sustaining expression of IL-6Rα, gp130, ICOS, and Bcl6; single or double knockout shows additive defects, with combined Lef1/Tcf7 deletion severely impairing TFH differentiation and germinal center formation.","method":"Single and double conditional knockout mice, LCMV infection model, flow cytometry, gene expression analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — combinatorial genetic epistasis with defined molecular targets, replicated by independent lab same year","pmids":["26214741"],"is_preprint":false},{"year":2015,"finding":"TCF-1 is required for efficient generation of all adult ILC subsets; TCF-1-high early ILC progenitors (EILPs) are the earliest ILC-committed progenitors lacking T and B lymphocyte potential, indicating TCF-1 upregulation marks the earliest stage of ILC fate specification.","method":"TCF-1 reporter mice, conditional knockout, lineage tracing, adoptive transfer, flow cytometry","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reporter mice plus loss-of-function with defined progenitor hierarchy established through adoptive transfer","pmids":["26280998"],"is_preprint":false},{"year":2018,"finding":"TCF-1 is a lineage-determining transcription factor that establishes the epigenetic identity of T cells by targeting silent chromatin and opening regulatory regions at the earliest stages of T cell development; TCF-1 expression in fibroblasts generates de novo chromatin accessibility even at regions with repressive marks, inducing T cell-restricted genes, demonstrating pioneer transcription factor activity.","method":"ATAC-seq across eight T cell developmental stages, TCF-1 loss-of-function, ectopic TCF-1 expression in fibroblasts, chromatin accessibility profiling","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — genome-wide chromatin profiling across multiple stages, gain- and loss-of-function, cross-lineage ectopic expression, multiple orthogonal methods","pmids":["29466756"],"is_preprint":false},{"year":2018,"finding":"TCF-1 and HEB share ~7,000 DNA-binding sites genome-wide in CD4+CD8+ thymocytes; TCF-1 displaces nucleosomes to allow chromatin accessibility and prevents Notch-mediated proteasomal degradation of HEB, thereby enabling TCF-1/HEB cooperation in establishing the epigenetic and transcription profiles of DP thymocytes.","method":"ChIP-seq, ATAC-seq, Co-IP, Notch pathway manipulation, TCF-1 and HEB conditional knockouts","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — genome-wide binding data, nucleosome displacement demonstrated, protein interaction by Co-IP, genetic epistasis","pmids":["30420627"],"is_preprint":false},{"year":2019,"finding":"TCF-1 mediates an early fate bifurcation between terminal KLRG1hi effectors and KLRG1lo exhausted T cell precursors during chronic infection; it promotes Eomes expression (mediating T-bet-to-Eomes transition) and drives c-Myb expression controlling Bcl-2 and survival, while repressing terminal effector development; PD-1 stabilizes the TCF-1+ precursor pool.","method":"scRNA-seq, lineage tracing, Tcf7 conditional knockout, LCMV chronic infection model, flow cytometry","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — single-cell resolution plus conditional KO with defined downstream target regulation; replicated across multiple groups","pmids":["31606264"],"is_preprint":false},{"year":2019,"finding":"TCF-1 limits Tc17 cell differentiation in DP thymocytes through sequential suppression of the transcription factors MAF and RORγt, in parallel with TCF-1-driven modulation of chromatin state; ablation of TCF-1 enhances Tc17 development.","method":"Conditional TCF-1 knockout, ATAC-seq, flow cytometry, gene expression analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined molecular pathway (MAF→RORγt suppression) and chromatin profiling","pmids":["31142588"],"is_preprint":false},{"year":2019,"finding":"TCF-1 enforces ILC lineage commitment by using a pre-existing regulatory landscape established in upstream lymphoid precursors to bind chromatin in EILPs, and is required for generation of committed EILPs but not specified EILPs, demonstrating a stage-specific epigenetic mechanism for TCF-1 in ILC commitment.","method":"scRNA-seq, conditional TCF-1 knockout, ATAC-seq, adoptive transfer","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — single-cell approaches plus chromatin accessibility profiling and functional epistasis","pmids":["31358996"],"is_preprint":false},{"year":2019,"finding":"TCF-1 has intrinsic histone deacetylase (HDAC) activity that is essential for its functions in T cell and ILC lineage commitment and maintenance, functioning independently of Wnt/beta-catenin in certain contexts.","method":"Review citing experimental evidence from primary studies","journal":"Trends in immunology","confidence":"Low","confidence_rationale":"Tier 4 / Weak — stated in a review without direct experimental citation in the abstract; mechanistic claim not directly supported by experiment in this paper","pmids":["31734149"],"is_preprint":false},{"year":2020,"finding":"Tcf7 (Tcf1) counteracts cytolytic differentiation in effector-phase CD8 T cells and sustains expression of conserved adult stem-cell genes critical for stemness; Tcf7hi effector cells lacking cytolytic differentiation markers quantitatively yield central memory CD8 T cells, as demonstrated by lineage tracing.","method":"Lineage tracing, Tcf7 conditional knockout, scRNA-seq, flow cytometry, LCMV acute infection model","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — lineage tracing plus conditional KO with defined molecular phenotype and downstream target regulation","pmids":["33128876"],"is_preprint":false},{"year":2020,"finding":"Tcf7 promoter DNA methylation contributes to TCF-1 downregulation in exhausted CD8 T cells; repeat antigenic stimulation induces Tcf7 promoter methylation concurrent with exhaustion, demonstrated in a novel in vitro exhaustion model validated against in vivo LCMV-exhausted cells.","method":"In vitro repeated peptide stimulation exhaustion model, bisulfite sequencing/DNA methylation analysis, transcriptomic comparison with LCMV-exhausted cells","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct epigenetic assay (promoter methylation) with functional validation in an established exhaustion model","pmids":["32579593"],"is_preprint":false},{"year":2021,"finding":"TCF-1 directly regulates CD8 T cell expansion capacity; CRISPR-Cas9 deletion of TCF-1 in human primary T cells directly reduces secondary expansion capacity, establishing a cell-intrinsic role for TCF-1 in regulating stem-like memory properties independent of viral load.","method":"CRISPR-Cas9 gene editing in human primary T cells, expansion assays, flow cytometry","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct CRISPR loss-of-function in primary human cells with defined functional readout","pmids":["33351785"],"is_preprint":false},{"year":2021,"finding":"Regnase-1 directly targets Tcf7 mRNA; Regnase-1 deficiency augments TCF-1 expression in CAR-T cells leading to increased formation of TCF-1+ precursor exhausted T cells (Tpex) with enhanced tumor clearance and long-term persistence.","method":"Regnase-1 knockout, RNA binding/mRNA stability assay, phenotypic profiling, xenograft model","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct mRNA targeting demonstrated plus functional KO phenotype, single lab","pmids":["33690816"],"is_preprint":false},{"year":2021,"finding":"TCF-1 primarily suppresses transcription of genes co-bound by Foxp3 in Treg cells; TCF-1 deficiency in Tregs promotes alternative signaling pathways, TH17-like characteristics, and gut-homing properties, while strongly suppressing T cell cytotoxicity but impairing control of CD4+ T cell polarization and inflammation.","method":"Treg-specific TCF-1 conditional knockout, scRNA-seq, flow cytometry, tumor model","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with scRNA-seq revealing direct target gene suppression and defined functional phenotype","pmids":["34385712"],"is_preprint":false},{"year":2022,"finding":"TCF-1 promotes chromatin interactions across topologically associating domain (TAD) boundaries in T cell progenitors; co-occupancy of TCF-1 and CTCF alters TAD structure, and TCF-1-dependent long-range interactions are linked to deposition of H3K27ac and recruitment of the cohesin-loading factor NIPBL at active enhancers.","method":"Hi-C/3D genome profiling, ATAC-seq, ChIP-seq for H3K27ac and NIPBL, TCF-1 gain- and loss-of-function","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — genome-wide 3D genome profiling with gain- and loss-of-function, multiple orthogonal epigenomic methods","pmids":["35726060"],"is_preprint":false},{"year":2022,"finding":"TGF-β signaling is not required for generation of stem-like PD-1+TCF-1+ CD8 T cells during chronic LCMV infection but is critical for maintaining their stem-like state and quiescence; TGF-β regulates the unique transcriptional program of the stem-like subset including expression of inhibitory receptors specifically expressed on these cells.","method":"TGF-β signaling conditional knockout, LCMV chronic infection, scRNA-seq, flow cytometry","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined transcriptional program differences, mechanistic pathway placement upstream of TCF-1+ stem-like state maintenance","pmids":["35980386"],"is_preprint":false},{"year":2022,"finding":"TCF-1-mediated early T cell development proceeds through a kinetic competition between TCF-1 (Tcf7) and Gata3 as T cell-promoting factors versus Spi1 (PU.1) and Bcl11a as progenitor factors, with an unexpected guidance role for Erg; defined by single-cell CRISPR disruption at distinct early stages of T cell development.","method":"Single-cell CRISPR disruption, scRNA-seq with batch indexing, synchronized in vitro differentiation","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single-cell CRISPR screen with scRNA-seq, single lab, novel method","pmids":["35594339"],"is_preprint":false},{"year":2017,"finding":"Ubiquitin C-terminal hydrolase 37 (Uch37), a deubiquitinase, interacts with Tcf7 and promotes its binding to target gene promoters; the deubiquitinating activity of Uch37 is not required for Tcf7 protein stability but is required for chromatin occupancy of Tcf7 at target genes in both Xenopus embryos and human liver cancer cells.","method":"Co-immunoprecipitation, biochemical assays for deubiquitinase activity, chromatin occupancy assay (ChIP), Xenopus in vivo analysis, human cell experiments","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ChIP demonstrating mechanism; cross-system validation in Xenopus and human cells; single lab","pmids":["28198400"],"is_preprint":false},{"year":2010,"finding":"Runx2 directly activates the Tcf7 promoter in chondrocytes; Runx2 induces Tcf7 and Lef1 expression in Runx2-/- chondrocytes, and dominant-negative Tcf7 transgenic mice show retarded chondrocyte maturation and reduced proliferation, placing Tcf7 downstream of Runx2 in skeletal development.","method":"Microarray, reporter assay, Runx2-/- chondrocyte reconstitution, dominant-negative Tcf7 transgenic mice, BrdU labeling, in situ hybridization","journal":"Journal of bone and mineral metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay plus transgenic mouse with defined cellular phenotype, single lab, multiple methods","pmids":["20890621"],"is_preprint":false},{"year":2009,"finding":"In normal colon cells, a dominant-negative TCF-1 isoform (dnTCF-1) is equally distributed between nuclear and cytoplasmic compartments; in colon cancer cells, TCF-1 is predominantly cytoplasmic due to active nuclear export directed by an autocrine Wnt ligand requiring Ca2+/calmodulin-dependent kinase II (CaMKII) activity for secretion, demonstrating Wnt/CaMKII-regulated nuclear export of TCF-1.","method":"Subcellular fractionation, nuclear export assay, pharmacological inhibition of CaMKII, Wnt ligand conditioned medium experiments","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiments with mechanistic pathway dissection, single lab","pmids":["19749792"],"is_preprint":false},{"year":2012,"finding":"TCF7 regulates a self-renewal/differentiation switch in multipotential hematopoietic progenitor cells independent of autocrine Wnt signaling; ChIP-seq identified TCF7 target genes, and TCF7 binds to RUNX1 promoter regions and is necessary for production of short RUNX1 isoforms but not long isoforms, suggesting coordinated regulation between TCF7 and short RUNX1.","method":"RNA-seq, ChIP-seq, TCF7 knockdown, EML hematopoietic cell model","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide binding (ChIP-seq) plus loss-of-function with isoform-specific readout; single lab","pmids":["22412390"],"is_preprint":false},{"year":2020,"finding":"A shared 1 kb regulatory element controls initiation of Tcf7 expression in both T cells and ILCs; within this element, a Notch binding site is important for Tcf7 initiation in T cells but not ILCs, demonstrating lineage-specific transcriptional control of Tcf7 through a common cis-regulatory element.","method":"Regulatory element reporter assay, Notch binding site mutation, conditional reporter mice","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined regulatory element with site-specific mutation, single lab","pmids":["32265924"],"is_preprint":false},{"year":2010,"finding":"IL-4/STAT6 signaling downregulates TCF-1 expression in human naive CD4+ T cells specifically targeting the shorter dominant-negative TCF-1 isoforms; STAT6 binds TCF-1 gene regulatory regions as demonstrated by EMSA and ChIP, providing a feedback mechanism linking IL-4 signaling to TCF-1 isoform-specific suppression.","method":"EMSA, ChIP, STAT6 knockdown, qRT-PCR in primary human T cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct DNA binding and ChIP demonstrated plus knockdown, single lab with multiple methods","pmids":["20980261"],"is_preprint":false},{"year":2015,"finding":"TCF-1-mediated Wnt signaling directly activates alpha-defensin HD-5 and HD-6 transcription in intestinal Paneth cells through cooperation with beta-catenin; reporter gene assays, in vitro promoter binding (EMSA), and Tcf-1 knockout mice demonstrate TCF-1 binding to three distinct TCF binding sites in the HD-5 and HD-6 promoters.","method":"Reporter gene assay, EMSA, Tcf-1 knockout mouse, qRT-PCR","journal":"American journal of physiology - Gastrointestinal and liver physiology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro binding (EMSA), functional reporter assay, and in vivo KO with defined target genes; single lab","pmids":["24994854"],"is_preprint":false},{"year":2015,"finding":"AF1q specifically binds to TCF7 (by Co-IP) and functions as a transcriptional co-factor that activates CD44 and multiple downstream TCF7/LEF1 target genes, promoting breast cancer cell proliferation, migration, and metastasis.","method":"Co-immunoprecipitation, reporter assay, knockdown/overexpression, xenograft model","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP plus functional assays in multiple model systems; single lab","pmids":["26079538"],"is_preprint":false},{"year":2023,"finding":"Targeted deletion of TCF-1 in gamma-delta T-IELs in the colon induces a distinct effector profile and reduces colon tumor formation in mice, establishing TCF-1 as a transcriptional suppressor of effector/cytotoxic function specifically in colonic intraepithelial gamma-delta T cells.","method":"Gamma-delta T cell-specific conditional TCF-1 knockout, colon tumor model, flow cytometry, scRNA-seq","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-type-specific conditional KO with defined effector phenotype and functional tumor readout","pmids":["37801516"],"is_preprint":false},{"year":2022,"finding":"IL-10R signaling through STAT3 maintains the PD-1int TCF-1+ CD8 T cell subset; loss of Il10rb or Stat3 decreases PD-1int TCF-1+ CD8 T cell frequencies and mechanistically alters chromatin accessibility, disrupting cooperativity between NFAT and AP-1 transcription factors and promoting an NFAT-dependent exhaustion program.","method":"Il10rb/Stat3 conditional knockout, scRNA-seq, ATAC-seq, flow cytometry, CLL mouse model","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with chromatin accessibility profiling identifying direct mechanistic pathway upstream of TCF-1+ cell maintenance; single lab","pmids":["34879221"],"is_preprint":false}],"current_model":"TCF-1 (encoded by TCF7) is a T cell-specific HMG-box transcription factor that recognizes a conserved AACAAAG-type motif in the minor groove of DNA, functions as a context-dependent transcriptional activator or repressor, acts as a pioneer factor that opens silent chromatin and establishes the epigenetic identity of T cells, cooperates with beta-catenin as a Wnt pathway effector to promote thymocyte survival and CD8 memory differentiation, directly represses LEF-1 and the IL-17 locus via epigenetic modifications to prevent malignancy and Th17 excess, drives TFH differentiation by binding the Bcl6 promoter and Prdm1 regulatory regions, interacts with Runx3 to silence Cd4 in cytotoxic lineage cells, controls 3D genome organization by co-occupying sites with CTCF and recruiting NIPBL, and maintains stem-like progenitor exhausted CD8 T cell populations critical for anti-tumor immunity and responses to checkpoint blockade."},"narrative":{"mechanistic_narrative":"TCF-1 (encoded by TCF7) is a T lineage-specific HMG-box transcription factor that establishes and maintains the epigenetic and transcriptional identity of T and innate lymphoid cells [PMID:1989880, PMID:29466756]. It recognizes a conserved A/T A/T CAAA/GAG heptamer motif in the enhancers of T cell-specific genes (CD3-epsilon, TCR-alpha/beta/delta) through minor-groove contacts mediated by its single HMG box, while a separate, context-dependent activation domain confers T cell-preferential transactivation [PMID:1827138, PMID:1836958, PMID:1639073, PMID:8253387]. Acting as a pioneer factor, TCF-1 targets silent chromatin, displaces nucleosomes, and generates de novo accessibility even at repressively marked regions, and it organizes the 3D genome by co-occupying sites with CTCF and recruiting the cohesin loader NIPBL to drive long-range enhancer interactions and H3K27ac deposition [PMID:29466756, PMID:30420627, PMID:35726060]. Through these activities TCF-1 specifies T lineage fate downstream of Notch by inducing Gata3, Bcl11b, and TCR genes, and marks the earliest ILC-committed progenitors [PMID:21814277, PMID:26280998, PMID:31358996]. As a Wnt pathway effector, TCF-1 partners with beta-catenin/gamma-catenin via its N-terminal catenin-binding domain to sustain thymocyte survival (via Bcl-xL) and to program CD8 central memory differentiation [PMID:10221643, PMID:11477404, PMID:20457902]. TCF-1 also operates as a context-dependent repressor: it directly silences LEF-1 to act as a tumor suppressor preventing T-ALL-like malignancy, maintains repressive chromatin at the IL-17 locus, and suppresses cytolytic/Tc17 programs through MAF and RORgt [PMID:23103132, PMID:21935461, PMID:31142588, PMID:33128876]. It functions as a transcriptional hub for helper and follicular fate by activating Th-POK and Bcl6 while repressing Blimp1, and cooperates with partners including Runx3 (to silence Cd4), HEB, and LEF-1 [PMID:24836425, PMID:26214740, PMID:26214741, PMID:30420627]. In CD8 T cells responding to chronic antigen, TCF-1 maintains the stem-like, PD-1+ progenitor exhausted population that underlies anti-tumor immunity and responses to checkpoint blockade, a function it also exerts in human T cells [PMID:31606264, PMID:33128876, PMID:33351785].","teleology":[{"year":1991,"claim":"Established TCF-1 as a T cell-specific sequence-specific DNA-binding transcription factor, defining its molecular identity and the enhancers it controls.","evidence":"Protein purification, gel retardation, cotransfection/reporter assays and cDNA cloning across CD3-epsilon and TCR enhancers in human and mouse","pmids":["1989880","1827138","1836958"],"confidence":"High","gaps":["Did not establish coactivator requirements","In vivo function untested at this stage"]},{"year":1992,"claim":"Defined the mechanism of DNA recognition, showing the HMG box binds the heptamer through minor-groove contacts.","evidence":"Methylation and DEPC interference footprinting plus base-substitution analysis comparing TCF-1 and SRY HMG boxes","pmids":["1639073"],"confidence":"High","gaps":["No co-crystal structure of TCF-1-DNA complex","Did not address how binding translates to activation versus repression"]},{"year":1993,"claim":"Separated DNA binding from transactivation, identifying a context-dependent, T cell-preferential activation domain that requires cooperative enhancer occupancy.","evidence":"GAL4 fusion transactivation with deletion/substitution mutants in T cell lines","pmids":["8253387"],"confidence":"High","gaps":["Identity of the cooperating factor at the time unresolved","Activation domain interaction partners not biochemically defined"]},{"year":1996,"claim":"Showed dual-promoter architecture and alternative splicing generate functionally distinct isoforms, some resembling LEF-1 and some lacking transactivation capacity.","evidence":"cDNA cloning, 5' RACE, Western blot and reporter assays","pmids":["8622675","7579399"],"confidence":"High","gaps":["Isoform-specific in vivo functions not delineated","Regulation of isoform choice not resolved"]},{"year":1999,"claim":"Placed TCF-1 as the Wnt effector in T cells through beta-catenin interaction, revealing a cell-type-specific mode of Wnt pathway activation distinct from fibroblasts.","evidence":"TCF reporter assays with dominant-negative GSK-3beta and lithium across cell types","pmids":["10221643"],"confidence":"Medium","gaps":["Reporter-based, did not test endogenous target genes","Mechanism of GSK-3beta independence unexplained"]},{"year":2001,"claim":"Demonstrated the catenin-binding domain is genetically required for thymocyte survival, placing TCF-1/beta-catenin upstream of anti-apoptotic Bcl-xL.","evidence":"Catenin-binding domain mutant knock-in, Bcl-2 transgene rescue, reporter mice and Wnt blockade","pmids":["11477404","11265645","15890681"],"confidence":"High","gaps":["Direct binding of TCF-1 to Bcl-xL regulatory regions not shown","Relative contributions of beta- vs gamma-catenin partially resolved"]},{"year":2010,"claim":"Defined TCF-1 as essential for CD8 central memory differentiation, extending its Wnt-dependent role from thymus to peripheral memory programming.","evidence":"Tcf-1 knockout with LCMV infection, adoptive transfer, catenin-binding domain mutants","pmids":["20457902"],"confidence":"High","gaps":["Direct memory-gene targets not fully mapped at this stage","Chromatin mechanism not yet addressed"]},{"year":2011,"claim":"Established TCF-1 as a T-lineage specification factor acting downstream of Notch and as an epigenetic repressor of the IL-17 locus.","evidence":"Forced expression in Notch1-deficient progenitors and ChIP for histone marks at IL-17 in knockout mice","pmids":["21814277","21935461"],"confidence":"High","gaps":["Mechanism of de novo chromatin opening not yet demonstrated","Direct versus indirect target relationships incompletely resolved"]},{"year":2012,"claim":"Identified TCF-1 as a direct repressor of LEF-1 and a tumor suppressor whose loss drives T-ALL-like malignancy.","evidence":"Tcf7 knockout, conditional Lef1 rescue, ChIP and histopathology","pmids":["23103132"],"confidence":"High","gaps":["Molecular basis of activation-versus-repression switch unresolved","Human leukemia relevance addressed only by analogy"]},{"year":2014,"claim":"Resolved how TCF-1 specifies helper versus cytotoxic identity, through Th-POK activation and physical cooperation with Runx3 to silence Cd4.","evidence":"Conditional knockout, Co-IP of TCF-1/Runx3 and ChIP","pmids":["24836425"],"confidence":"High","gaps":["Stoichiometry/structure of TCF-1-Runx3 complex unknown","Reciprocal validation of interaction limited"]},{"year":2015,"claim":"Defined TCF-1 (with LEF-1) as a TFH-commitment hub binding Bcl6 and Prdm1 regulatory regions, and as required for ILC progenitor generation.","evidence":"ChIP of Bcl6/Prdm1, single and double Tcf7/Lef1 conditional knockouts, reporter mice and lineage tracing","pmids":["26214740","26214741","26280998"],"confidence":"High","gaps":["Direct cofactors at Bcl6/Prdm1 not fully defined","Redundancy mechanisms with LEF-1 partially resolved"]},{"year":2018,"claim":"Demonstrated pioneer-factor activity and nucleosome displacement, showing TCF-1 opens silent chromatin and cooperates with HEB by protecting it from Notch-mediated degradation.","evidence":"ATAC-seq across developmental stages, ectopic expression in fibroblasts, ChIP-seq and Co-IP","pmids":["29466756","30420627"],"confidence":"High","gaps":["Structural basis of nucleosome engagement undefined","Which domains mediate pioneering not dissected"]},{"year":2019,"claim":"Positioned TCF-1 at the bifurcation between terminal effectors and stem-like exhausted CD8 precursors during chronic infection, and as a brake on Tc17 differentiation.","evidence":"scRNA-seq, lineage tracing, conditional knockout in LCMV chronic infection and ATAC-seq","pmids":["31606264","31142588","31358996"],"confidence":"High","gaps":["Direct targets driving the precursor program incompletely mapped","Upstream signals stabilizing TCF-1+ cells not yet defined here"]},{"year":2020,"claim":"Showed TCF-1 sustains stemness and counters cytolytic differentiation in CD8 cells, while its own downregulation in exhaustion is enforced by Tcf7 promoter DNA methylation.","evidence":"Lineage tracing, conditional knockout, scRNA-seq and bisulfite sequencing in exhaustion models","pmids":["33128876","32579593"],"confidence":"High","gaps":["Enzymes depositing Tcf7 methylation not identified","Causality of methylation versus consequence partially resolved"]},{"year":2021,"claim":"Confirmed a cell-intrinsic role for TCF-1 in human T cell expansion and revealed post-transcriptional control of Tcf7 by Regnase-1 governing Tpex formation.","evidence":"CRISPR-Cas9 in human primary T cells and Regnase-1 knockout with mRNA targeting in CAR-T xenografts","pmids":["33351785","33690816"],"confidence":"High","gaps":["Therapeutic durability of Tcf7 modulation untested long-term","Regnase-1 target specificity single-lab"]},{"year":2022,"claim":"Established TCF-1 as an organizer of 3D genome architecture through CTCF co-occupancy and NIPBL recruitment, and clarified upstream signals (TGF-beta, IL-10R/STAT3) maintaining TCF-1+ stem-like cells.","evidence":"Hi-C, ChIP-seq for H3K27ac/NIPBL, single-cell CRISPR, and conditional knockouts of TGF-beta and Il10rb/Stat3 pathways","pmids":["35726060","35980386","34879221","35594339"],"confidence":"High","gaps":["Direct biochemical interaction of TCF-1 with NIPBL/cohesin not shown","How TCF-1 selects loop-forming sites unresolved"]},{"year":2021,"claim":"Extended TCF-1's repressor role to regulatory and tissue-resident lineages, suppressing Foxp3-co-bound genes in Tregs and effector programs in colonic gamma-delta T-IELs.","evidence":"Cell-type-specific conditional knockouts with scRNA-seq in Treg and gamma-delta IEL tumor models","pmids":["34385712","37801516"],"confidence":"High","gaps":["Mechanism of TCF-1/Foxp3 co-repression not biochemically defined","Lineage-specific cofactors not identified"]},{"year":null,"claim":"How TCF-1 mechanistically toggles between activation and repression, engages nucleosomes structurally, and physically couples to cohesin/NIPBL to build TADs remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of TCF-1 on nucleosomal DNA","Direct TCF-1-NIPBL/cohesin interaction unconfirmed","Domain logic of activator-versus-repressor switching undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,3]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,4,16,18]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[21,22]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,37]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[21,22,32]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,4,16,18]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,10,11,13]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[13,18,23,27]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[14,21,22,32]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[7,15,20]}],"complexes":[],"partners":["CTNNB1","JUP","RUNX3","HEB","LEF1","NIPBL","CTCF","UCHL5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P36402","full_name":"Transcription factor 7","aliases":["T-cell-specific transcription factor 1","T-cell factor 1","TCF-1"],"length_aa":384,"mass_kda":41.6,"function":"Transcriptional activator involved in T-cell lymphocyte differentiation. Necessary for the survival of CD4(+) CD8(+) immature thymocytes. Isoforms lacking the N-terminal CTNNB1 binding domain cannot fulfill this role. Binds to the T-lymphocyte-specific enhancer element (5'-WWCAAAG-3') found in the promoter of the CD3E gene. Represses expression of the T-cell receptor gamma gene in alpha-beta T-cell lineages (By similarity). Required for the development of natural killer receptor-positive lymphoid tissue inducer T-cells (By similarity). TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7 and CTNNB1. May also act as feedback transcriptional repressor of CTNNB1 and TCF7L2 target genes","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P36402/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TCF7","classification":"Not Classified","n_dependent_lines":12,"n_total_lines":1208,"dependency_fraction":0.009933774834437087},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TCF7","total_profiled":1310},"omim":[{"mim_id":"616333","title":"WNT SIGNALING PATHWAY ACTIVATING NONCODING RNA; WSPAR","url":"https://www.omim.org/entry/616333"},{"mim_id":"612034","title":"APC2 REGULATOR OF WNT SIGNALING PATHWAY 2; APC2","url":"https://www.omim.org/entry/612034"},{"mim_id":"611784","title":"GENERAL TRANSCRIPTION FACTOR 3C, POLYPEPTIDE 6; GTF3C6","url":"https://www.omim.org/entry/611784"},{"mim_id":"611731","title":"APC REGULATOR OF WNT SIGNALING PATHWAY; APC","url":"https://www.omim.org/entry/611731"},{"mim_id":"606359","title":"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A","url":"https://www.omim.org/entry/606359"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":518.8}],"url":"https://www.proteinatlas.org/search/TCF7"},"hgnc":{"alias_symbol":["TCF-1"],"prev_symbol":[]},"alphafold":{"accession":"P36402","domains":[{"cath_id":"1.10.30.10","chopping":"269-334","consensus_level":"medium","plddt":94.0256,"start":269,"end":334}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P36402","model_url":"https://alphafold.ebi.ac.uk/files/AF-P36402-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P36402-F1-predicted_aligned_error_v6.png","plddt_mean":57.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TCF7","jax_strain_url":"https://www.jax.org/strain/search?query=TCF7"},"sequence":{"accession":"P36402","fasta_url":"https://rest.uniprot.org/uniprotkb/P36402.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P36402/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P36402"}},"corpus_meta":[{"pmid":"31606264","id":"PMC_31606264","title":"TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31606264","citation_count":572,"is_preprint":false},{"pmid":"1989880","id":"PMC_1989880","title":"Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box.","date":"1991","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1989880","citation_count":513,"is_preprint":false},{"pmid":"21814277","id":"PMC_21814277","title":"A critical role for TCF-1 in T-lineage specification and differentiation.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21814277","citation_count":338,"is_preprint":false},{"pmid":"20457902","id":"PMC_20457902","title":"Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20457902","citation_count":305,"is_preprint":false},{"pmid":"26214741","id":"PMC_26214741","title":"LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26214741","citation_count":289,"is_preprint":false},{"pmid":"26280998","id":"PMC_26280998","title":"TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26280998","citation_count":242,"is_preprint":false},{"pmid":"34534439","id":"PMC_34534439","title":"Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes.","date":"2021","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/34534439","citation_count":232,"is_preprint":false},{"pmid":"8223271","id":"PMC_8223271","title":"Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis.","date":"1993","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8223271","citation_count":228,"is_preprint":false},{"pmid":"11477404","id":"PMC_11477404","title":"The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival.","date":"2001","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11477404","citation_count":201,"is_preprint":false},{"pmid":"26214740","id":"PMC_26214740","title":"The transcription factor TCF-1 initiates the differentiation of T(FH) cells during acute viral infection.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26214740","citation_count":201,"is_preprint":false},{"pmid":"1639073","id":"PMC_1639073","title":"Sequence-specific interaction of the HMG box proteins TCF-1 and SRY occurs within the minor groove of a Watson-Crick double helix.","date":"1992","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1639073","citation_count":199,"is_preprint":false},{"pmid":"9780167","id":"PMC_9780167","title":"Critical involvement of Tcf-1 in expansion of thymocytes.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9780167","citation_count":187,"is_preprint":false},{"pmid":"8622675","id":"PMC_8622675","title":"Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8622675","citation_count":176,"is_preprint":false},{"pmid":"29466756","id":"PMC_29466756","title":"Lineage-Determining Transcription Factor TCF-1 Initiates the Epigenetic Identity of T Cells.","date":"2018","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/29466756","citation_count":172,"is_preprint":false},{"pmid":"33128876","id":"PMC_33128876","title":"Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation.","date":"2020","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/33128876","citation_count":162,"is_preprint":false},{"pmid":"34172072","id":"PMC_34172072","title":"Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis.","date":"2021","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34172072","citation_count":159,"is_preprint":false},{"pmid":"8253387","id":"PMC_8253387","title":"The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8253387","citation_count":157,"is_preprint":false},{"pmid":"11265645","id":"PMC_11265645","title":"Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription.","date":"2001","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11265645","citation_count":154,"is_preprint":false},{"pmid":"23103132","id":"PMC_23103132","title":"The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy.","date":"2012","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23103132","citation_count":152,"is_preprint":false},{"pmid":"24836425","id":"PMC_24836425","title":"TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells.","date":"2014","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24836425","citation_count":142,"is_preprint":false},{"pmid":"18065431","id":"PMC_18065431","title":"Insertional mutagenesis by the Tol2 transposon-mediated enhancer trap approach generated mutations in two developmental genes: tcf7 and synembryn-like.","date":"2008","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18065431","citation_count":139,"is_preprint":false},{"pmid":"1827138","id":"PMC_1827138","title":"Cloning of murine TCF-1, a T cell-specific transcription factor interacting with functional motifs in the CD3-epsilon and T cell receptor alpha enhancers.","date":"1991","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1827138","citation_count":137,"is_preprint":false},{"pmid":"2083253","id":"PMC_2083253","title":"Purification of TCF-1 alpha, a T-cell-specific transcription factor that activates the T-cell receptor C alpha gene enhancer in a context-dependent manner.","date":"1990","source":"The New biologist","url":"https://pubmed.ncbi.nlm.nih.gov/2083253","citation_count":117,"is_preprint":false},{"pmid":"24038093","id":"PMC_24038093","title":"TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24038093","citation_count":115,"is_preprint":false},{"pmid":"9064330","id":"PMC_9064330","title":"Involvement of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell development in the thymus.","date":"1996","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9064330","citation_count":112,"is_preprint":false},{"pmid":"34879221","id":"PMC_34879221","title":"Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity.","date":"2021","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/34879221","citation_count":105,"is_preprint":false},{"pmid":"31358996","id":"PMC_31358996","title":"The transcription factor TCF-1 enforces commitment to the innate lymphoid cell lineage.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31358996","citation_count":101,"is_preprint":false},{"pmid":"15365098","id":"PMC_15365098","title":"IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: impact on thymocyte development.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15365098","citation_count":97,"is_preprint":false},{"pmid":"35472220","id":"PMC_35472220","title":"In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35472220","citation_count":95,"is_preprint":false},{"pmid":"33913198","id":"PMC_33913198","title":"Role of TCF-1 in differentiation, exhaustion, and memory of CD8+ T cells: A review.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/33913198","citation_count":93,"is_preprint":false},{"pmid":"22412390","id":"PMC_22412390","title":"Tcf7 is an important regulator of the switch of self-renewal and differentiation in a multipotential hematopoietic cell line.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22412390","citation_count":86,"is_preprint":false},{"pmid":"31734149","id":"PMC_31734149","title":"Control of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1.","date":"2019","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31734149","citation_count":84,"is_preprint":false},{"pmid":"25436980","id":"PMC_25436980","title":"MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25436980","citation_count":83,"is_preprint":false},{"pmid":"33351785","id":"PMC_33351785","title":"TCF-1 regulates HIV-specific CD8+ T cell expansion capacity.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/33351785","citation_count":79,"is_preprint":false},{"pmid":"32066947","id":"PMC_32066947","title":"HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells.","date":"2020","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32066947","citation_count":78,"is_preprint":false},{"pmid":"35637103","id":"PMC_35637103","title":"BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen.","date":"2022","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/35637103","citation_count":76,"is_preprint":false},{"pmid":"33690816","id":"PMC_33690816","title":"Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33690816","citation_count":76,"is_preprint":false},{"pmid":"35980386","id":"PMC_35980386","title":"TGF-β regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35980386","citation_count":72,"is_preprint":false},{"pmid":"22535304","id":"PMC_22535304","title":"β-catenin/TCF-1 pathway in T cell development and differentiation.","date":"2012","source":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22535304","citation_count":70,"is_preprint":false},{"pmid":"26193896","id":"PMC_26193896","title":"Elevated Hepatic miR-22-3p Expression Impairs Gluconeogenesis by Silencing the Wnt-Responsive Transcription Factor Tcf7.","date":"2015","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26193896","citation_count":70,"is_preprint":false},{"pmid":"35487986","id":"PMC_35487986","title":"TCF-1: a maverick in T cell development and function.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35487986","citation_count":69,"is_preprint":false},{"pmid":"34385712","id":"PMC_34385712","title":"TCF-1 controls Treg cell functions that regulate inflammation, CD8+ T cell cytotoxicity and severity of colon cancer.","date":"2021","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34385712","citation_count":68,"is_preprint":false},{"pmid":"30111633","id":"PMC_30111633","title":"Human Lymph Nodes Maintain TCF-1hi Memory T Cells with High Functional Potential and Clonal Diversity throughout Life.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30111633","citation_count":68,"is_preprint":false},{"pmid":"10549625","id":"PMC_10549625","title":"Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1.","date":"1999","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10549625","citation_count":68,"is_preprint":false},{"pmid":"10221643","id":"PMC_10221643","title":"Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.","date":"1999","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10221643","citation_count":66,"is_preprint":false},{"pmid":"24551047","id":"PMC_24551047","title":"Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24551047","citation_count":63,"is_preprint":false},{"pmid":"32579593","id":"PMC_32579593","title":"Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation.","date":"2020","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/32579593","citation_count":63,"is_preprint":false},{"pmid":"25869100","id":"PMC_25869100","title":"Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25869100","citation_count":60,"is_preprint":false},{"pmid":"37708030","id":"PMC_37708030","title":"STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1+ NK cells.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37708030","citation_count":59,"is_preprint":false},{"pmid":"37624910","id":"PMC_37624910","title":"Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1+ PD-1+ CD8 T cells.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37624910","citation_count":57,"is_preprint":false},{"pmid":"35726060","id":"PMC_35726060","title":"TCF-1 promotes chromatin interactions across topologically associating domains in T cell progenitors.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35726060","citation_count":56,"is_preprint":false},{"pmid":"30420627","id":"PMC_30420627","title":"TCF-1 and HEB cooperate to establish the epigenetic and transcription profiles of CD4+CD8+ thymocytes.","date":"2018","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30420627","citation_count":56,"is_preprint":false},{"pmid":"12731066","id":"PMC_12731066","title":"Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition.","date":"2003","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12731066","citation_count":56,"is_preprint":false},{"pmid":"15890681","id":"PMC_15890681","title":"Cooperating pre-T-cell receptor and TCF-1-dependent signals ensure thymocyte survival.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15890681","citation_count":54,"is_preprint":false},{"pmid":"27806296","id":"PMC_27806296","title":"Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27806296","citation_count":49,"is_preprint":false},{"pmid":"7579399","id":"PMC_7579399","title":"The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes.","date":"1995","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/7579399","citation_count":48,"is_preprint":false},{"pmid":"31142588","id":"PMC_31142588","title":"TCF-1 limits the formation of Tc17 cells via repression of the MAF-RORγt axis.","date":"2019","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31142588","citation_count":47,"is_preprint":false},{"pmid":"1836958","id":"PMC_1836958","title":"TCF-1, a T cell-specific transcription factor of the HMG box family, interacts with sequence motifs in the TCR beta and TCR delta enhancers.","date":"1991","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1836958","citation_count":45,"is_preprint":false},{"pmid":"12707037","id":"PMC_12707037","title":"Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.","date":"2003","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12707037","citation_count":45,"is_preprint":false},{"pmid":"21935461","id":"PMC_21935461","title":"Critical role of TCF-1 in repression of the IL-17 gene.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21935461","citation_count":44,"is_preprint":false},{"pmid":"12951064","id":"PMC_12951064","title":"Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12951064","citation_count":43,"is_preprint":false},{"pmid":"36809763","id":"PMC_36809763","title":"The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1+ CD8+ T cells in chronic viral infection.","date":"2023","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/36809763","citation_count":42,"is_preprint":false},{"pmid":"35594339","id":"PMC_35594339","title":"Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35594339","citation_count":42,"is_preprint":false},{"pmid":"35428876","id":"PMC_35428876","title":"Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35428876","citation_count":40,"is_preprint":false},{"pmid":"19749792","id":"PMC_19749792","title":"A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19749792","citation_count":40,"is_preprint":false},{"pmid":"24994854","id":"PMC_24994854","title":"TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and -6: implications for Crohn's disease.","date":"2014","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24994854","citation_count":40,"is_preprint":false},{"pmid":"27683056","id":"PMC_27683056","title":"Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27683056","citation_count":38,"is_preprint":false},{"pmid":"18045485","id":"PMC_18045485","title":"The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes.","date":"2007","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18045485","citation_count":38,"is_preprint":false},{"pmid":"1618927","id":"PMC_1618927","title":"Identification of a core motif that is recognized by three members of the HMG class of transcriptional regulators: IRE-ABP, SRY, and TCF-1 alpha.","date":"1992","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1618927","citation_count":37,"is_preprint":false},{"pmid":"26714756","id":"PMC_26714756","title":"Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.","date":"2015","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26714756","citation_count":37,"is_preprint":false},{"pmid":"12765974","id":"PMC_12765974","title":"A polymorphism in the TCF7 gene, C883A, is associated with type 1 diabetes.","date":"2003","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/12765974","citation_count":36,"is_preprint":false},{"pmid":"26079538","id":"PMC_26079538","title":"AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26079538","citation_count":36,"is_preprint":false},{"pmid":"36565920","id":"PMC_36565920","title":"Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth.","date":"2022","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/36565920","citation_count":35,"is_preprint":false},{"pmid":"32265924","id":"PMC_32265924","title":"A Shared Regulatory Element Controls the Initiation of Tcf7 Expression During Early T Cell and Innate Lymphoid Cell Developments.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32265924","citation_count":33,"is_preprint":false},{"pmid":"38101610","id":"PMC_38101610","title":"Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38101610","citation_count":32,"is_preprint":false},{"pmid":"34309413","id":"PMC_34309413","title":"Saikosaponin-d Alleviates Renal Inflammation and Cell Apoptosis in a Mouse Model of Sepsis via TCF7/FOSL1/Matrix Metalloproteinase 9 Inhibition.","date":"2021","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/34309413","citation_count":30,"is_preprint":false},{"pmid":"30778164","id":"PMC_30778164","title":"Opposing roles of TCF7/LEF1 and TCF7L2 in cyclin D2 and Bmp4 expression and cardiomyocyte cell cycle control during late heart development.","date":"2019","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30778164","citation_count":30,"is_preprint":false},{"pmid":"34047386","id":"PMC_34047386","title":"TCF-1 maintains CD8+ T cell stemness in tumor microenvironment.","date":"2021","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/34047386","citation_count":29,"is_preprint":false},{"pmid":"30528236","id":"PMC_30528236","title":"Long non-coding RNA TCF7 contributes to the growth and migration of airway smooth muscle cells in asthma through targeting TIMMDC1/Akt axis.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30528236","citation_count":29,"is_preprint":false},{"pmid":"27766570","id":"PMC_27766570","title":"Long noncoding RNA TCF7 promotes invasiveness and self-renewal of human non-small cell lung cancer cells.","date":"2016","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/27766570","citation_count":29,"is_preprint":false},{"pmid":"19956102","id":"PMC_19956102","title":"Evidence for association of the TCF7 locus with type I diabetes.","date":"2009","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/19956102","citation_count":29,"is_preprint":false},{"pmid":"15649465","id":"PMC_15649465","title":"lin-17/Frizzled and lin-18 regulate POP-1/TCF-1 localization and cell type specification during C. elegans vulval development.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15649465","citation_count":29,"is_preprint":false},{"pmid":"30563094","id":"PMC_30563094","title":"The Disruption of the β-Catenin/TCF-1/STAT3 Signaling Axis by 4-Acetylantroquinonol B Inhibits the Tumorigenesis and Cancer Stem-Cell-Like Properties of Glioblastoma Cells, In Vitro and In Vivo.","date":"2018","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/30563094","citation_count":29,"is_preprint":false},{"pmid":"15765502","id":"PMC_15765502","title":"Expression pattern of zebrafish tcf7 suggests unexplored domains of Wnt/beta-catenin activity.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15765502","citation_count":28,"is_preprint":false},{"pmid":"36681742","id":"PMC_36681742","title":"BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells.","date":"2023","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/36681742","citation_count":28,"is_preprint":false},{"pmid":"20980261","id":"PMC_20980261","title":"Inhibition of suppressive T cell factor 1 (TCF-1) isoforms in naive CD4+ T cells is mediated by IL-4/STAT6 signaling.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20980261","citation_count":28,"is_preprint":false},{"pmid":"9259402","id":"PMC_9259402","title":"Ectopic activation of lymphoid high mobility group-box transcription factor TCF-1 and overexpression in colorectal cancer cells.","date":"1997","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9259402","citation_count":28,"is_preprint":false},{"pmid":"30225781","id":"PMC_30225781","title":"Down-regulation of lncTCF7 inhibits cell migration and invasion in colorectal cancer via inhibiting TCF7 expression.","date":"2018","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/30225781","citation_count":27,"is_preprint":false},{"pmid":"20890621","id":"PMC_20890621","title":"Regulation of Tcf7 by Runx2 in chondrocyte maturation and proliferation.","date":"2010","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/20890621","citation_count":27,"is_preprint":false},{"pmid":"24858819","id":"PMC_24858819","title":"Wnt signaling transcription factors TCF-1 and LEF-1 are upregulated in malignant astrocytic brain tumors.","date":"2014","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/24858819","citation_count":27,"is_preprint":false},{"pmid":"22466651","id":"PMC_22466651","title":"Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.","date":"2012","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/22466651","citation_count":27,"is_preprint":false},{"pmid":"1577072","id":"PMC_1577072","title":"A common ancestor of the mammalian transcription factors TCF-1 and TCF-1 alpha/LEF-1 expressed in chicken T cells.","date":"1992","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1577072","citation_count":27,"is_preprint":false},{"pmid":"28220803","id":"PMC_28220803","title":"TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.","date":"2017","source":"Prostate cancer and prostatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28220803","citation_count":26,"is_preprint":false},{"pmid":"37801516","id":"PMC_37801516","title":"TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37801516","citation_count":25,"is_preprint":false},{"pmid":"32868912","id":"PMC_32868912","title":"Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution.","date":"2020","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32868912","citation_count":25,"is_preprint":false},{"pmid":"28198400","id":"PMC_28198400","title":"Ubiquitin C-terminal hydrolase37 regulates Tcf7 DNA binding for the activation of Wnt signalling.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28198400","citation_count":24,"is_preprint":false},{"pmid":"28485543","id":"PMC_28485543","title":"Andrographolide Induces Cell Cycle Arrest and Apoptosis of Chondrosarcoma by Targeting TCF-1/SOX9 Axis.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28485543","citation_count":24,"is_preprint":false},{"pmid":"12711535","id":"PMC_12711535","title":"Tcf-1 expression during Xenopus development.","date":"2003","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/12711535","citation_count":23,"is_preprint":false},{"pmid":"33705946","id":"PMC_33705946","title":"Soybean-derived gma-miR159a alleviates colon tumorigenesis by suppressing TCF7/MYC in mice.","date":"2021","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33705946","citation_count":22,"is_preprint":false},{"pmid":"29358218","id":"PMC_29358218","title":"T Cell Factor 7 (TCF7)/TCF1 Feedback Controls Osteocalcin Signaling in Brown Adipocytes Independent of the Wnt/β-Catenin Pathway.","date":"2018","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29358218","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47743,"output_tokens":10344,"usd":0.149195,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21195,"output_tokens":5217,"usd":0.1182,"stage2_stop_reason":"end_turn"},"total_usd":0.267395,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1991,\n      \"finding\": \"TCF-1 was identified and cloned as a T lymphocyte-specific transcription factor containing a single sequence-specific HMG box that binds a heptamer motif in the CD3-epsilon enhancer; upon cotransfection into non-T cells, TCF-1 transactivated through its cognate motif, establishing it as a T cell-specific transcriptional activator.\",\n      \"method\": \"Protein purification, gel retardation assay, cotransfection/reporter assay, cDNA cloning\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — original cloning paper with in vitro binding assay, functional transactivation assay, and replicated across multiple subsequent studies\",\n      \"pmids\": [\"1989880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Murine TCF-1 recognizes the same sequence motif in the CD3-epsilon enhancer as human TCF-1, and the HMG box region alone is sufficient for sequence-specific DNA binding; TCF-1 also binds specifically to a functional element in the TCR-alpha enhancer.\",\n      \"method\": \"Gel retardation assay, methylation interference, deletion analysis, Northern blot, in situ hybridization\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal in vitro assays with deletion mapping; replicated in independent lab\",\n      \"pmids\": [\"1827138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"TCF-1 binds specifically to the T beta 5 element of the TCR-beta enhancer and the T delta 7 element of the TCR-delta enhancer, defining a consensus motif A/T A/T CAAA/GAG recognized by TCF-1 across multiple T cell-specific gene enhancers.\",\n      \"method\": \"Gel retardation analysis\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro binding assay, single lab, single method\",\n      \"pmids\": [\"1836958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The HMG boxes of TCF-1 and SRY recognize the heptamer motif predominantly through contacts in the minor groove of DNA, not the major groove, as demonstrated by methylation interference and DEPC carbethoxylation interference footprinting, and by T-to-C and A-to-inosine substitutions that change major groove but not minor groove surfaces.\",\n      \"method\": \"Methylation interference footprinting, DEPC interference footprinting, base substitution analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods establishing mechanism of DNA recognition in a single rigorous study\",\n      \"pmids\": [\"1639073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"TCF-1/hLEF contains a context-dependent transcriptional activation domain (approximately amino acids 80–256) that is separate from the HMG box and is preferentially active in T cells; this activation domain requires TCF-2 binding at flanking sites within the TCR-alpha enhancer for full activity, demonstrating cooperative enhancer function.\",\n      \"method\": \"GAL4 fusion transactivation assay, deletion mutagenesis, clustered amino acid substitution, cotransfection/reporter assay in T cell lines\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution with GAL4 fusions plus multiple deletion/substitution mutants in a single rigorous study\",\n      \"pmids\": [\"8253387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Human TCF-1 protein is expressed exclusively in the nucleus of T lineage cells in normal tissues, produces multiple isoforms (25–55 kDa) by alternative splicing, and is detectable in all stages of T cell malignancy tested, consistent with a T cell-specific nuclear transcription factor function.\",\n      \"method\": \"Monoclonal antibody generation, Western blot, immunohistochemistry, immunocytochemistry\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct protein localization by antibody-based methods, multiple tissues, single lab\",\n      \"pmids\": [\"7579399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"TCF-1 is encoded by an extensively alternatively spliced gene with a dual-promoter architecture; an alternative upstream promoter adds 116 amino acids to the N-terminus, producing isoforms resembling LEF-1 that can transactivate through the TCR-alpha enhancer, while shorter isoforms lack this capacity, establishing functional differences between TCF-1 isoforms.\",\n      \"method\": \"Western blot, cDNA cloning, 5' RACE, PCR, cotransfection/reporter assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal methods (cloning, RACE, functional reporter assay) establishing isoform-specific functional differences\",\n      \"pmids\": [\"8622675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TCF-1 deficiency causes progressive failure of thymocyte expansion at two DN stages (CD44+CD25+ and CD44-CD25-) normally characterized by extensive proliferation; this defect is cell-intrinsic as Tcf-1-/- progenitors fail to expand in normal thymic environments, implicating TCF-1 (as a Wnt/beta-catenin effector) in driving DN thymocyte proliferation.\",\n      \"method\": \"Tcf-1 knockout mouse analysis, fetal thymic organ culture, intrathymic injection of knockout progenitors, flow cytometry\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean loss-of-function in vivo plus cell-intrinsic rescue experiments with defined cellular phenotype\",\n      \"pmids\": [\"9780167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"TCF-1 binds to two sites in the Ly49A promoter and regulates its transcriptional activity; TCF-1 determines the size of the Ly49A NK cell subset in vivo in a dosage-dependent manner, establishing TCF-1 as a trans-acting factor for clonal NK cell receptor acquisition.\",\n      \"method\": \"Gel shift/promoter binding assay, Tcf-1 knockout and heterozygous mouse analysis, flow cytometry\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct promoter binding demonstrated plus in vivo dosage-dependent phenotype\",\n      \"pmids\": [\"10549625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"In T cells, TCF-1 becomes transcriptionally active through interaction with beta-catenin, indicating the Wnt signal transduction pathway is operational in T lymphocytes; however, unlike fibroblasts, GSK-3beta inhibition alone (by lithium or dominant-negative GSK-3beta) is insufficient to activate TCF-dependent transcription in T cells, revealing a cell-type-specific difference in Wnt pathway regulation.\",\n      \"method\": \"TCF reporter assay in T cells vs. fibroblasts, dominant-negative GSK-3beta expression, lithium treatment, cotransfection\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assays in two cell types with multiple perturbations, single lab\",\n      \"pmids\": [\"10221643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The beta-catenin-binding domain of TCF-1 is required for survival of immature CD4+CD8+ double-positive thymocytes; loss of TCF-1 leads to Bcl-xL downregulation and accelerated apoptosis, which is rescued by a Bcl-2 transgene, placing TCF-1/beta-catenin upstream of anti-apoptotic gene expression in thymocyte survival.\",\n      \"method\": \"TCF-1 knockout mouse analysis with catenin-binding domain mutant knock-in, Bcl-2 transgene rescue, flow cytometry, Western blot\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic rescue experiment with domain-specific mutant and transgenic rescue, epistasis established\",\n      \"pmids\": [\"11477404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Wnt1 and Wnt4 signals activate TCF-dependent transcriptional activity in thymocytes (demonstrated using TCF-LacZ reporter mice); the interaction of beta-catenin with TCF-1 is required for full thymocyte development, and retroviral expression of soluble Wnt receptor mutants blocking Wnt signaling inhibits thymocyte development in vitro.\",\n      \"method\": \"TCF-LacZ reporter mice, retroviral expression of dominant-negative Wnt receptor, in vitro thymocyte culture, flow cytometry\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo reporter assay plus functional blockade experiment placing TCF-1 as downstream effector of Wnt in thymus\",\n      \"pmids\": [\"11265645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TCF-1 ensures survival of pre-TCR+ thymocytes via its N-terminal catenin-binding domain; pre-TCR signaling significantly induces TCF-1 expression and activates a Wnt/catenin/TCF reporter transgene in vivo, while Wnt signals provide beta-catenin as coactivator, demonstrating cooperation between pre-TCR and Wnt/TCF-1 pathways for thymocyte survival.\",\n      \"method\": \"TCF-1 catenin-binding domain mutant mice, TCF reporter transgene in vivo, gamma-catenin knockout analysis, flow cytometry\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-specific genetic dissection plus in vivo pathway reporter, single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"15890681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TCF-1 programs CD8 memory T cell fate; Tcf-1-deficient CD8 T cells lack memory precursor cells (detectable at peak of primary response) and fail to expand upon secondary challenge; this function requires the catenin-binding domain in TCF-1 and depends on beta-catenin and gamma-catenin as coactivators, establishing the Wnt/TCF-1 pathway as essential for CD8 central memory differentiation.\",\n      \"method\": \"Tcf-1 knockout mouse, LCMV infection model, adoptive transfer, catenin-binding domain mutant analysis, flow cytometry\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined phenotype, domain-specific requirement established, mechanistic pathway placement\",\n      \"pmids\": [\"20457902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TCF-1 represses IL-17 gene expression via epigenetic modifications during T cell development; TCF-1 deficiency leads to hyperacetylation and H3K4 trimethylation (active marks) at the IL-17 locus in thymocytes, and this epigenetic state is maintained in peripheral T cells, demonstrating TCF-1 maintains chromatin in a repressive state at the IL-17 locus.\",\n      \"method\": \"Tcf-1 knockout mouse, chromatin immunoprecipitation (ChIP) for histone marks, Rag1-/- reconstitution, flow cytometry, EAE model\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating epigenetic mechanism plus in vivo reconstitution with defined phenotypic readout\",\n      \"pmids\": [\"21935461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TCF-1 is a critical regulator of T-lineage specification; forced expression of TCF-1 in bone marrow progenitors drives T-lineage development even in the absence of T-inductive Notch1 signals, and TCF-1 upregulates T-cell essential genes including Gata3, Bcl11b, and TCR components, placing TCF-1 downstream of Notch in a T cell specification cascade.\",\n      \"method\": \"Conditional TCF-1 overexpression in bone marrow progenitors, Notch1-deficient background, flow cytometry, gene expression analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function epistasis experiment in defined genetic background with multiple downstream target validation\",\n      \"pmids\": [\"21814277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TCF-1 directly represses LEF-1 expression in early thymocytes; Tcf7-/- mice develop T cell malignancy resembling T-ALL in which LEF-1 is aberrantly upregulated, and conditional inactivation of Lef1 greatly delayed or prevented malignancy in Tcf7-/- mice, establishing TCF-1 as a direct transcriptional repressor of LEF-1 and a tumor suppressor in T cell development.\",\n      \"method\": \"Tcf7 knockout mouse, conditional Lef1 knockout rescue, ChIP (direct repression), flow cytometry, histopathology\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding/repression by ChIP plus genetic epistasis rescue experiment, two orthogonal approaches\",\n      \"pmids\": [\"23103132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TCF-1 and LEF-1 promote CD4+ T cell fate by directly and positively regulating the transcription factor Th-POK; additionally, TCF-1 physically interacts with Runx3 to cooperatively silence Cd4 in CD8-lineage T cells, demonstrating TCF-1 operates through distinct molecular interactions (Th-POK activation; Runx3 cooperation) to specify helper vs. cytotoxic T cell identity.\",\n      \"method\": \"Conditional knockout in DP thymocytes, Co-immunoprecipitation (TCF-1/Runx3 interaction), ChIP, flow cytometry\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with defined lineage phenotype, direct protein interaction by Co-IP, ChIP for target regulation, multiple orthogonal methods\",\n      \"pmids\": [\"24836425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TCF-1 initiates TFH differentiation by directly binding the Bcl6 promoter to promote Bcl-6 expression and the Prdm1 5' regulatory regions to repress Blimp1 expression, placing TCF-1 as a transcriptional hub upstream of the Bcl-6/Blimp1 axis for TFH cell commitment.\",\n      \"method\": \"ChIP (direct promoter binding), Tcf7 conditional knockout, viral infection model, flow cytometry\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct promoter occupancy by ChIP, loss-of-function phenotype, dual target validation in one study\",\n      \"pmids\": [\"26214740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LEF-1 and TCF-1 cooperatively regulate TFH differentiation by establishing responsiveness of naive CD4+ T cells to TFH signals and sustaining expression of IL-6Rα, gp130, ICOS, and Bcl6; single or double knockout shows additive defects, with combined Lef1/Tcf7 deletion severely impairing TFH differentiation and germinal center formation.\",\n      \"method\": \"Single and double conditional knockout mice, LCMV infection model, flow cytometry, gene expression analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — combinatorial genetic epistasis with defined molecular targets, replicated by independent lab same year\",\n      \"pmids\": [\"26214741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TCF-1 is required for efficient generation of all adult ILC subsets; TCF-1-high early ILC progenitors (EILPs) are the earliest ILC-committed progenitors lacking T and B lymphocyte potential, indicating TCF-1 upregulation marks the earliest stage of ILC fate specification.\",\n      \"method\": \"TCF-1 reporter mice, conditional knockout, lineage tracing, adoptive transfer, flow cytometry\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reporter mice plus loss-of-function with defined progenitor hierarchy established through adoptive transfer\",\n      \"pmids\": [\"26280998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TCF-1 is a lineage-determining transcription factor that establishes the epigenetic identity of T cells by targeting silent chromatin and opening regulatory regions at the earliest stages of T cell development; TCF-1 expression in fibroblasts generates de novo chromatin accessibility even at regions with repressive marks, inducing T cell-restricted genes, demonstrating pioneer transcription factor activity.\",\n      \"method\": \"ATAC-seq across eight T cell developmental stages, TCF-1 loss-of-function, ectopic TCF-1 expression in fibroblasts, chromatin accessibility profiling\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — genome-wide chromatin profiling across multiple stages, gain- and loss-of-function, cross-lineage ectopic expression, multiple orthogonal methods\",\n      \"pmids\": [\"29466756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TCF-1 and HEB share ~7,000 DNA-binding sites genome-wide in CD4+CD8+ thymocytes; TCF-1 displaces nucleosomes to allow chromatin accessibility and prevents Notch-mediated proteasomal degradation of HEB, thereby enabling TCF-1/HEB cooperation in establishing the epigenetic and transcription profiles of DP thymocytes.\",\n      \"method\": \"ChIP-seq, ATAC-seq, Co-IP, Notch pathway manipulation, TCF-1 and HEB conditional knockouts\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — genome-wide binding data, nucleosome displacement demonstrated, protein interaction by Co-IP, genetic epistasis\",\n      \"pmids\": [\"30420627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF-1 mediates an early fate bifurcation between terminal KLRG1hi effectors and KLRG1lo exhausted T cell precursors during chronic infection; it promotes Eomes expression (mediating T-bet-to-Eomes transition) and drives c-Myb expression controlling Bcl-2 and survival, while repressing terminal effector development; PD-1 stabilizes the TCF-1+ precursor pool.\",\n      \"method\": \"scRNA-seq, lineage tracing, Tcf7 conditional knockout, LCMV chronic infection model, flow cytometry\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — single-cell resolution plus conditional KO with defined downstream target regulation; replicated across multiple groups\",\n      \"pmids\": [\"31606264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF-1 limits Tc17 cell differentiation in DP thymocytes through sequential suppression of the transcription factors MAF and RORγt, in parallel with TCF-1-driven modulation of chromatin state; ablation of TCF-1 enhances Tc17 development.\",\n      \"method\": \"Conditional TCF-1 knockout, ATAC-seq, flow cytometry, gene expression analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined molecular pathway (MAF→RORγt suppression) and chromatin profiling\",\n      \"pmids\": [\"31142588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF-1 enforces ILC lineage commitment by using a pre-existing regulatory landscape established in upstream lymphoid precursors to bind chromatin in EILPs, and is required for generation of committed EILPs but not specified EILPs, demonstrating a stage-specific epigenetic mechanism for TCF-1 in ILC commitment.\",\n      \"method\": \"scRNA-seq, conditional TCF-1 knockout, ATAC-seq, adoptive transfer\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — single-cell approaches plus chromatin accessibility profiling and functional epistasis\",\n      \"pmids\": [\"31358996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF-1 has intrinsic histone deacetylase (HDAC) activity that is essential for its functions in T cell and ILC lineage commitment and maintenance, functioning independently of Wnt/beta-catenin in certain contexts.\",\n      \"method\": \"Review citing experimental evidence from primary studies\",\n      \"journal\": \"Trends in immunology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — stated in a review without direct experimental citation in the abstract; mechanistic claim not directly supported by experiment in this paper\",\n      \"pmids\": [\"31734149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Tcf7 (Tcf1) counteracts cytolytic differentiation in effector-phase CD8 T cells and sustains expression of conserved adult stem-cell genes critical for stemness; Tcf7hi effector cells lacking cytolytic differentiation markers quantitatively yield central memory CD8 T cells, as demonstrated by lineage tracing.\",\n      \"method\": \"Lineage tracing, Tcf7 conditional knockout, scRNA-seq, flow cytometry, LCMV acute infection model\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — lineage tracing plus conditional KO with defined molecular phenotype and downstream target regulation\",\n      \"pmids\": [\"33128876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Tcf7 promoter DNA methylation contributes to TCF-1 downregulation in exhausted CD8 T cells; repeat antigenic stimulation induces Tcf7 promoter methylation concurrent with exhaustion, demonstrated in a novel in vitro exhaustion model validated against in vivo LCMV-exhausted cells.\",\n      \"method\": \"In vitro repeated peptide stimulation exhaustion model, bisulfite sequencing/DNA methylation analysis, transcriptomic comparison with LCMV-exhausted cells\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct epigenetic assay (promoter methylation) with functional validation in an established exhaustion model\",\n      \"pmids\": [\"32579593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TCF-1 directly regulates CD8 T cell expansion capacity; CRISPR-Cas9 deletion of TCF-1 in human primary T cells directly reduces secondary expansion capacity, establishing a cell-intrinsic role for TCF-1 in regulating stem-like memory properties independent of viral load.\",\n      \"method\": \"CRISPR-Cas9 gene editing in human primary T cells, expansion assays, flow cytometry\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct CRISPR loss-of-function in primary human cells with defined functional readout\",\n      \"pmids\": [\"33351785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Regnase-1 directly targets Tcf7 mRNA; Regnase-1 deficiency augments TCF-1 expression in CAR-T cells leading to increased formation of TCF-1+ precursor exhausted T cells (Tpex) with enhanced tumor clearance and long-term persistence.\",\n      \"method\": \"Regnase-1 knockout, RNA binding/mRNA stability assay, phenotypic profiling, xenograft model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct mRNA targeting demonstrated plus functional KO phenotype, single lab\",\n      \"pmids\": [\"33690816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TCF-1 primarily suppresses transcription of genes co-bound by Foxp3 in Treg cells; TCF-1 deficiency in Tregs promotes alternative signaling pathways, TH17-like characteristics, and gut-homing properties, while strongly suppressing T cell cytotoxicity but impairing control of CD4+ T cell polarization and inflammation.\",\n      \"method\": \"Treg-specific TCF-1 conditional knockout, scRNA-seq, flow cytometry, tumor model\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with scRNA-seq revealing direct target gene suppression and defined functional phenotype\",\n      \"pmids\": [\"34385712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TCF-1 promotes chromatin interactions across topologically associating domain (TAD) boundaries in T cell progenitors; co-occupancy of TCF-1 and CTCF alters TAD structure, and TCF-1-dependent long-range interactions are linked to deposition of H3K27ac and recruitment of the cohesin-loading factor NIPBL at active enhancers.\",\n      \"method\": \"Hi-C/3D genome profiling, ATAC-seq, ChIP-seq for H3K27ac and NIPBL, TCF-1 gain- and loss-of-function\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — genome-wide 3D genome profiling with gain- and loss-of-function, multiple orthogonal epigenomic methods\",\n      \"pmids\": [\"35726060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TGF-β signaling is not required for generation of stem-like PD-1+TCF-1+ CD8 T cells during chronic LCMV infection but is critical for maintaining their stem-like state and quiescence; TGF-β regulates the unique transcriptional program of the stem-like subset including expression of inhibitory receptors specifically expressed on these cells.\",\n      \"method\": \"TGF-β signaling conditional knockout, LCMV chronic infection, scRNA-seq, flow cytometry\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined transcriptional program differences, mechanistic pathway placement upstream of TCF-1+ stem-like state maintenance\",\n      \"pmids\": [\"35980386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TCF-1-mediated early T cell development proceeds through a kinetic competition between TCF-1 (Tcf7) and Gata3 as T cell-promoting factors versus Spi1 (PU.1) and Bcl11a as progenitor factors, with an unexpected guidance role for Erg; defined by single-cell CRISPR disruption at distinct early stages of T cell development.\",\n      \"method\": \"Single-cell CRISPR disruption, scRNA-seq with batch indexing, synchronized in vitro differentiation\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-cell CRISPR screen with scRNA-seq, single lab, novel method\",\n      \"pmids\": [\"35594339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Ubiquitin C-terminal hydrolase 37 (Uch37), a deubiquitinase, interacts with Tcf7 and promotes its binding to target gene promoters; the deubiquitinating activity of Uch37 is not required for Tcf7 protein stability but is required for chromatin occupancy of Tcf7 at target genes in both Xenopus embryos and human liver cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, biochemical assays for deubiquitinase activity, chromatin occupancy assay (ChIP), Xenopus in vivo analysis, human cell experiments\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ChIP demonstrating mechanism; cross-system validation in Xenopus and human cells; single lab\",\n      \"pmids\": [\"28198400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Runx2 directly activates the Tcf7 promoter in chondrocytes; Runx2 induces Tcf7 and Lef1 expression in Runx2-/- chondrocytes, and dominant-negative Tcf7 transgenic mice show retarded chondrocyte maturation and reduced proliferation, placing Tcf7 downstream of Runx2 in skeletal development.\",\n      \"method\": \"Microarray, reporter assay, Runx2-/- chondrocyte reconstitution, dominant-negative Tcf7 transgenic mice, BrdU labeling, in situ hybridization\",\n      \"journal\": \"Journal of bone and mineral metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay plus transgenic mouse with defined cellular phenotype, single lab, multiple methods\",\n      \"pmids\": [\"20890621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In normal colon cells, a dominant-negative TCF-1 isoform (dnTCF-1) is equally distributed between nuclear and cytoplasmic compartments; in colon cancer cells, TCF-1 is predominantly cytoplasmic due to active nuclear export directed by an autocrine Wnt ligand requiring Ca2+/calmodulin-dependent kinase II (CaMKII) activity for secretion, demonstrating Wnt/CaMKII-regulated nuclear export of TCF-1.\",\n      \"method\": \"Subcellular fractionation, nuclear export assay, pharmacological inhibition of CaMKII, Wnt ligand conditioned medium experiments\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiments with mechanistic pathway dissection, single lab\",\n      \"pmids\": [\"19749792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TCF7 regulates a self-renewal/differentiation switch in multipotential hematopoietic progenitor cells independent of autocrine Wnt signaling; ChIP-seq identified TCF7 target genes, and TCF7 binds to RUNX1 promoter regions and is necessary for production of short RUNX1 isoforms but not long isoforms, suggesting coordinated regulation between TCF7 and short RUNX1.\",\n      \"method\": \"RNA-seq, ChIP-seq, TCF7 knockdown, EML hematopoietic cell model\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide binding (ChIP-seq) plus loss-of-function with isoform-specific readout; single lab\",\n      \"pmids\": [\"22412390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A shared 1 kb regulatory element controls initiation of Tcf7 expression in both T cells and ILCs; within this element, a Notch binding site is important for Tcf7 initiation in T cells but not ILCs, demonstrating lineage-specific transcriptional control of Tcf7 through a common cis-regulatory element.\",\n      \"method\": \"Regulatory element reporter assay, Notch binding site mutation, conditional reporter mice\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined regulatory element with site-specific mutation, single lab\",\n      \"pmids\": [\"32265924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"IL-4/STAT6 signaling downregulates TCF-1 expression in human naive CD4+ T cells specifically targeting the shorter dominant-negative TCF-1 isoforms; STAT6 binds TCF-1 gene regulatory regions as demonstrated by EMSA and ChIP, providing a feedback mechanism linking IL-4 signaling to TCF-1 isoform-specific suppression.\",\n      \"method\": \"EMSA, ChIP, STAT6 knockdown, qRT-PCR in primary human T cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct DNA binding and ChIP demonstrated plus knockdown, single lab with multiple methods\",\n      \"pmids\": [\"20980261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TCF-1-mediated Wnt signaling directly activates alpha-defensin HD-5 and HD-6 transcription in intestinal Paneth cells through cooperation with beta-catenin; reporter gene assays, in vitro promoter binding (EMSA), and Tcf-1 knockout mice demonstrate TCF-1 binding to three distinct TCF binding sites in the HD-5 and HD-6 promoters.\",\n      \"method\": \"Reporter gene assay, EMSA, Tcf-1 knockout mouse, qRT-PCR\",\n      \"journal\": \"American journal of physiology - Gastrointestinal and liver physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro binding (EMSA), functional reporter assay, and in vivo KO with defined target genes; single lab\",\n      \"pmids\": [\"24994854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"AF1q specifically binds to TCF7 (by Co-IP) and functions as a transcriptional co-factor that activates CD44 and multiple downstream TCF7/LEF1 target genes, promoting breast cancer cell proliferation, migration, and metastasis.\",\n      \"method\": \"Co-immunoprecipitation, reporter assay, knockdown/overexpression, xenograft model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP plus functional assays in multiple model systems; single lab\",\n      \"pmids\": [\"26079538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Targeted deletion of TCF-1 in gamma-delta T-IELs in the colon induces a distinct effector profile and reduces colon tumor formation in mice, establishing TCF-1 as a transcriptional suppressor of effector/cytotoxic function specifically in colonic intraepithelial gamma-delta T cells.\",\n      \"method\": \"Gamma-delta T cell-specific conditional TCF-1 knockout, colon tumor model, flow cytometry, scRNA-seq\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific conditional KO with defined effector phenotype and functional tumor readout\",\n      \"pmids\": [\"37801516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"IL-10R signaling through STAT3 maintains the PD-1int TCF-1+ CD8 T cell subset; loss of Il10rb or Stat3 decreases PD-1int TCF-1+ CD8 T cell frequencies and mechanistically alters chromatin accessibility, disrupting cooperativity between NFAT and AP-1 transcription factors and promoting an NFAT-dependent exhaustion program.\",\n      \"method\": \"Il10rb/Stat3 conditional knockout, scRNA-seq, ATAC-seq, flow cytometry, CLL mouse model\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with chromatin accessibility profiling identifying direct mechanistic pathway upstream of TCF-1+ cell maintenance; single lab\",\n      \"pmids\": [\"34879221\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TCF-1 (encoded by TCF7) is a T cell-specific HMG-box transcription factor that recognizes a conserved AACAAAG-type motif in the minor groove of DNA, functions as a context-dependent transcriptional activator or repressor, acts as a pioneer factor that opens silent chromatin and establishes the epigenetic identity of T cells, cooperates with beta-catenin as a Wnt pathway effector to promote thymocyte survival and CD8 memory differentiation, directly represses LEF-1 and the IL-17 locus via epigenetic modifications to prevent malignancy and Th17 excess, drives TFH differentiation by binding the Bcl6 promoter and Prdm1 regulatory regions, interacts with Runx3 to silence Cd4 in cytotoxic lineage cells, controls 3D genome organization by co-occupying sites with CTCF and recruiting NIPBL, and maintains stem-like progenitor exhausted CD8 T cell populations critical for anti-tumor immunity and responses to checkpoint blockade.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TCF-1 (encoded by TCF7) is a T lineage-specific HMG-box transcription factor that establishes and maintains the epigenetic and transcriptional identity of T and innate lymphoid cells [#0, #21]. It recognizes a conserved A/T A/T CAAA/GAG heptamer motif in the enhancers of T cell-specific genes (CD3-epsilon, TCR-alpha/beta/delta) through minor-groove contacts mediated by its single HMG box, while a separate, context-dependent activation domain confers T cell-preferential transactivation [#1, #2, #3, #4]. Acting as a pioneer factor, TCF-1 targets silent chromatin, displaces nucleosomes, and generates de novo accessibility even at repressively marked regions, and it organizes the 3D genome by co-occupying sites with CTCF and recruiting the cohesin loader NIPBL to drive long-range enhancer interactions and H3K27ac deposition [#21, #22, #32]. Through these activities TCF-1 specifies T lineage fate downstream of Notch by inducing Gata3, Bcl11b, and TCR genes, and marks the earliest ILC-committed progenitors [#15, #20, #25]. As a Wnt pathway effector, TCF-1 partners with beta-catenin/gamma-catenin via its N-terminal catenin-binding domain to sustain thymocyte survival (via Bcl-xL) and to program CD8 central memory differentiation [#9, #10, #13]. TCF-1 also operates as a context-dependent repressor: it directly silences LEF-1 to act as a tumor suppressor preventing T-ALL-like malignancy, maintains repressive chromatin at the IL-17 locus, and suppresses cytolytic/Tc17 programs through MAF and RORgt [#16, #14, #24, #27]. It functions as a transcriptional hub for helper and follicular fate by activating Th-POK and Bcl6 while repressing Blimp1, and cooperates with partners including Runx3 (to silence Cd4), HEB, and LEF-1 [#17, #18, #19, #22]. In CD8 T cells responding to chronic antigen, TCF-1 maintains the stem-like, PD-1+ progenitor exhausted population that underlies anti-tumor immunity and responses to checkpoint blockade, a function it also exerts in human T cells [#23, #27, #29].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Established TCF-1 as a T cell-specific sequence-specific DNA-binding transcription factor, defining its molecular identity and the enhancers it controls.\",\n      \"evidence\": \"Protein purification, gel retardation, cotransfection/reporter assays and cDNA cloning across CD3-epsilon and TCR enhancers in human and mouse\",\n      \"pmids\": [\"1989880\", \"1827138\", \"1836958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish coactivator requirements\", \"In vivo function untested at this stage\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Defined the mechanism of DNA recognition, showing the HMG box binds the heptamer through minor-groove contacts.\",\n      \"evidence\": \"Methylation and DEPC interference footprinting plus base-substitution analysis comparing TCF-1 and SRY HMG boxes\",\n      \"pmids\": [\"1639073\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-crystal structure of TCF-1-DNA complex\", \"Did not address how binding translates to activation versus repression\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Separated DNA binding from transactivation, identifying a context-dependent, T cell-preferential activation domain that requires cooperative enhancer occupancy.\",\n      \"evidence\": \"GAL4 fusion transactivation with deletion/substitution mutants in T cell lines\",\n      \"pmids\": [\"8253387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the cooperating factor at the time unresolved\", \"Activation domain interaction partners not biochemically defined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Showed dual-promoter architecture and alternative splicing generate functionally distinct isoforms, some resembling LEF-1 and some lacking transactivation capacity.\",\n      \"evidence\": \"cDNA cloning, 5' RACE, Western blot and reporter assays\",\n      \"pmids\": [\"8622675\", \"7579399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Isoform-specific in vivo functions not delineated\", \"Regulation of isoform choice not resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Placed TCF-1 as the Wnt effector in T cells through beta-catenin interaction, revealing a cell-type-specific mode of Wnt pathway activation distinct from fibroblasts.\",\n      \"evidence\": \"TCF reporter assays with dominant-negative GSK-3beta and lithium across cell types\",\n      \"pmids\": [\"10221643\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reporter-based, did not test endogenous target genes\", \"Mechanism of GSK-3beta independence unexplained\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrated the catenin-binding domain is genetically required for thymocyte survival, placing TCF-1/beta-catenin upstream of anti-apoptotic Bcl-xL.\",\n      \"evidence\": \"Catenin-binding domain mutant knock-in, Bcl-2 transgene rescue, reporter mice and Wnt blockade\",\n      \"pmids\": [\"11477404\", \"11265645\", \"15890681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding of TCF-1 to Bcl-xL regulatory regions not shown\", \"Relative contributions of beta- vs gamma-catenin partially resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined TCF-1 as essential for CD8 central memory differentiation, extending its Wnt-dependent role from thymus to peripheral memory programming.\",\n      \"evidence\": \"Tcf-1 knockout with LCMV infection, adoptive transfer, catenin-binding domain mutants\",\n      \"pmids\": [\"20457902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct memory-gene targets not fully mapped at this stage\", \"Chromatin mechanism not yet addressed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established TCF-1 as a T-lineage specification factor acting downstream of Notch and as an epigenetic repressor of the IL-17 locus.\",\n      \"evidence\": \"Forced expression in Notch1-deficient progenitors and ChIP for histone marks at IL-17 in knockout mice\",\n      \"pmids\": [\"21814277\", \"21935461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of de novo chromatin opening not yet demonstrated\", \"Direct versus indirect target relationships incompletely resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified TCF-1 as a direct repressor of LEF-1 and a tumor suppressor whose loss drives T-ALL-like malignancy.\",\n      \"evidence\": \"Tcf7 knockout, conditional Lef1 rescue, ChIP and histopathology\",\n      \"pmids\": [\"23103132\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of activation-versus-repression switch unresolved\", \"Human leukemia relevance addressed only by analogy\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Resolved how TCF-1 specifies helper versus cytotoxic identity, through Th-POK activation and physical cooperation with Runx3 to silence Cd4.\",\n      \"evidence\": \"Conditional knockout, Co-IP of TCF-1/Runx3 and ChIP\",\n      \"pmids\": [\"24836425\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry/structure of TCF-1-Runx3 complex unknown\", \"Reciprocal validation of interaction limited\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined TCF-1 (with LEF-1) as a TFH-commitment hub binding Bcl6 and Prdm1 regulatory regions, and as required for ILC progenitor generation.\",\n      \"evidence\": \"ChIP of Bcl6/Prdm1, single and double Tcf7/Lef1 conditional knockouts, reporter mice and lineage tracing\",\n      \"pmids\": [\"26214740\", \"26214741\", \"26280998\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cofactors at Bcl6/Prdm1 not fully defined\", \"Redundancy mechanisms with LEF-1 partially resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated pioneer-factor activity and nucleosome displacement, showing TCF-1 opens silent chromatin and cooperates with HEB by protecting it from Notch-mediated degradation.\",\n      \"evidence\": \"ATAC-seq across developmental stages, ectopic expression in fibroblasts, ChIP-seq and Co-IP\",\n      \"pmids\": [\"29466756\", \"30420627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of nucleosome engagement undefined\", \"Which domains mediate pioneering not dissected\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Positioned TCF-1 at the bifurcation between terminal effectors and stem-like exhausted CD8 precursors during chronic infection, and as a brake on Tc17 differentiation.\",\n      \"evidence\": \"scRNA-seq, lineage tracing, conditional knockout in LCMV chronic infection and ATAC-seq\",\n      \"pmids\": [\"31606264\", \"31142588\", \"31358996\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct targets driving the precursor program incompletely mapped\", \"Upstream signals stabilizing TCF-1+ cells not yet defined here\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed TCF-1 sustains stemness and counters cytolytic differentiation in CD8 cells, while its own downregulation in exhaustion is enforced by Tcf7 promoter DNA methylation.\",\n      \"evidence\": \"Lineage tracing, conditional knockout, scRNA-seq and bisulfite sequencing in exhaustion models\",\n      \"pmids\": [\"33128876\", \"32579593\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzymes depositing Tcf7 methylation not identified\", \"Causality of methylation versus consequence partially resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Confirmed a cell-intrinsic role for TCF-1 in human T cell expansion and revealed post-transcriptional control of Tcf7 by Regnase-1 governing Tpex formation.\",\n      \"evidence\": \"CRISPR-Cas9 in human primary T cells and Regnase-1 knockout with mRNA targeting in CAR-T xenografts\",\n      \"pmids\": [\"33351785\", \"33690816\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Therapeutic durability of Tcf7 modulation untested long-term\", \"Regnase-1 target specificity single-lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established TCF-1 as an organizer of 3D genome architecture through CTCF co-occupancy and NIPBL recruitment, and clarified upstream signals (TGF-beta, IL-10R/STAT3) maintaining TCF-1+ stem-like cells.\",\n      \"evidence\": \"Hi-C, ChIP-seq for H3K27ac/NIPBL, single-cell CRISPR, and conditional knockouts of TGF-beta and Il10rb/Stat3 pathways\",\n      \"pmids\": [\"35726060\", \"35980386\", \"34879221\", \"35594339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical interaction of TCF-1 with NIPBL/cohesin not shown\", \"How TCF-1 selects loop-forming sites unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended TCF-1's repressor role to regulatory and tissue-resident lineages, suppressing Foxp3-co-bound genes in Tregs and effector programs in colonic gamma-delta T-IELs.\",\n      \"evidence\": \"Cell-type-specific conditional knockouts with scRNA-seq in Treg and gamma-delta IEL tumor models\",\n      \"pmids\": [\"34385712\", \"37801516\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of TCF-1/Foxp3 co-repression not biochemically defined\", \"Lineage-specific cofactors not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TCF-1 mechanistically toggles between activation and repression, engages nucleosomes structurally, and physically couples to cohesin/NIPBL to build TADs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of TCF-1 on nucleosomal DNA\", \"Direct TCF-1-NIPBL/cohesin interaction unconfirmed\", \"Domain logic of activator-versus-repressor switching undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 3]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4, 16, 18]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [21, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 37]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [21, 22, 32]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 4, 16, 18]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 10, 11, 13]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [13, 18, 23, 27]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [14, 21, 22, 32]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [7, 15, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CTNNB1\", \"JUP\", \"RUNX3\", \"HEB\", \"LEF1\", \"NIPBL\", \"CTCF\", \"UCHL5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}